Mycobacterial infections, both tuberculosis and nontuberculous, are more common in
patients with haematological malignancies and haematopoietic stem cell transplant …

Objective To assess in rheumatoid arthritis (RA) patients, treated with different
immunosuppressive therapies, the induction of SARS-CoV-2-specific immune response …

Caused by Mycobacterium tuberculosis, TB is the leading cause of death from an infectious
disease. HIV and diabetes are recognised risk factors for progression of TB disease and …

Background We conducted a review to compare the sensitivity, specificity, reproducibility,
and predictive ability of QuantiFERON-TB Gold Plus (QFT-Plus) with that of QuantiFERON …

Rapid, sensitive, accurate and portable diagnostics are a mainstay of modern medicine.
Tuberculosis is a disease that has been with us since time immemorial and, despite the fact …

Purpose The diagnostic accuracy of the interferon-gamma release assay (IGRA) in
immunosuppressed patients remains unclear. Methods A systematic review and meta …

• When interpreting a tuberculosis infection diagnostic test result and considering whether
someone is at risk of developing tuberculosis disease and would likely benefit from …

There is a crucial need for non-sputum-based TB tests. Here, we evaluate the performance
of RISK6, a human-blood transcriptomic signature, for TB screening, triage and treatment …

Recent global guidelines recommend Mycobacterium tuberculosis antigen-based skin tests,
such as the ESAT6-CFP10 (EC) skin test, as acceptable alternatives to the tuberculin skin …

Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold
Plus (QFT) testing. Previous studies showed that two-thirds of patients with negative QFT …